Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT03872466 · ClinicalTrials.gov registry record · NA

Glove Rehabilitation Application for Stroke Patients

A NA study of Virtual Reality and Occupational Therapy, sponsored by Barron Associates.

Completed
Registry status
NA
Development phase
21
Enrollment target
1
Study location

NCT03872466 is a NA study of Virtual Reality and Occupational Therapy that has completed, run by Barron Associates. The registered enrollment target is 21 participants, below the 91-participant average among 19 other Virtual Reality trials with a reported enrollment target (77% lower). The trial reports 1 study location across 1 state.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT03872466, a NA study of Virtual Reality and Occupational Therapy, has completed, sponsored by Barron Associates.

COMPLETED
Registry status
NA
Development phase
21 participants
Enrollment target
1
Study location

Study Summary

The University of Virginia (UVA) Director of Neurorehabilitation will lead GRASP randomized, controlled efficacy trials. The study will involve employment of the GRASP system in three one-hour sessions per week over eight weeks by stroke survivors suffering from ongoing hand function impairment.

Interventions

  • DEVICE GRASP HEP
  • BEHAVIORAL Usual Care Treatment (UCT)

Study Locations (1)

Virginia

  • UVA Outpatient Rehabilitation Clinic - Charlottesville

Trial Details

FieldValue
Enrollment Target 21 participants
Start Date 2020-06-11
Est. Completion 2022-04-26
Phase NA

Sponsor

Barron Associates

10 total trials

What the Registry Record Tells You About NCT03872466

The ClinicalTrials.gov registry entry for NCT03872466 describes a study currently listed as completed, categorized as NA. The registered enrollment target is 21 participants, a figure that helps gauge the scale of data the investigators plan to collect, below the 91-participant average among 19 other Virtual Reality trials with a reported enrollment target (77% lower). The listed sponsor is Barron Associates, which has 10 total studies on file at ClinicalTrials.gov.

The record links to 2 conditions, with Virtual Reality appearing as the primary indexed condition, and to 2 interventions - of which GRASP HEP is the first listed.

NCT03872466 reports 1 study location spanning 1 distinct geographic area - top geographies include Virginia.

Frequently Asked Questions

What is clinical trial NCT03872466 about?

NCT03872466 is a clinical study titled "Glove Rehabilitation Application for Stroke Patients". The University of Virginia (UVA) Director of Neurorehabilitation will lead GRASP randomized, controlled efficacy trials. The study will involve employment of the GRASP system in three one-hour sessions per week over eight weeks by stroke survivors suffering from ongoing hand function impairment.

What is the current status of trial NCT03872466?

This trial is currently completed. It is a NA study. The enrollment target is 21 participants. The study started on 2020-06-11. Estimated completion is 2022-04-26.

What conditions does trial NCT03872466 study?

This clinical trial studies the following conditions: Virtual Reality, Occupational Therapy.

What interventions are being tested in trial NCT03872466?

The interventions under investigation include: GRASP HEP (DEVICE), Usual Care Treatment (UCT) (BEHAVIORAL).

Who is sponsoring clinical trial NCT03872466?

This trial is sponsored by Barron Associates, which has 10 total clinical trials registered on ClinicalTrials.gov.

Where is trial NCT03872466 being conducted?

This trial has 1 study location across Virginia. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.

Similar trials for Virtual Reality

Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.

Data sourced from official public datasets. See our methodology for details. Retrieved and formatted by PlainTrial Editorial

Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.